Table 2.
C-tag affinity chromatography | Run 1 | Run 2 |
WNV | 2.70 ± 0.43 log10 | 2.70 ± 0.41 log10 |
PPV | 2.44 ± 0.56 log10 | 2.00 ± 0.38 log10 |
Virus-reduction filtration | Run 1 | Run 2 |
WNV | ≥5.00 ± 0.25 log10 | ≥5.17 ± 0.34 log10 |
PPV | ≥5.77 ± 0.36 log10 | ≥5.69 ± 0.38 log10 |
Overall reduction factors | ||
WNV | ≥7.70 ± 0.50 log10 | |
PPV | ≥7.69 ± 0.54 log10 |
Starting materials were spiked with the selected viruses and samples collected following the C-tag affinity chromatography or virus-reduction filtration process steps. Virus titer of each sample was determined by a 50% tissue culture infectious dose (TCID50) infectivity assay and the resultant virus log10 reduction factors are reported